Demographic Data, Medical Background, and Laboratory Results of Study and Control Groups
Parameter | Study group ( |
Control group ( |
|
---|---|---|---|
Age (yr) | 51.5 ± 18.9 | 51.1 ± 18.5 | 0.887 |
Sex, male | 21 (36.8) | 20 (33.3) | 0.691 |
Diabetes mellitus | 10 (17.5) | 7 (11.7) | 0.367 |
Hypertension | 19 (33.3) | 15 (25.0) | 0.321 |
Dyslipidemia | 12 (21.1) | 9 (15.0) | 0.394 |
Ischemic heart disease | 2 (3.5) | 4 (6.7) | 0.189 |
Laboratory result | |||
AST (7–37 IU/L) | 249.3 ± 204.5 | 85.7 ± 59.4 | < 0.01 |
ALT (0–40 IU/L) | 338.1 ± 259.2 | 95.5 ± 57.1 | < 0.01 |
ALP (30–120 IU/L) | 262.0 ± 123.5 | 116.1 ± 121.1 | < 0.01 |
GGT (7–49 IU/L) | 464.0 ± 344.2 | 206.1 ± 130.1 | < 0.01 |
Bilirubin (0.2–1.5 mg/dL) | 4.3 ± 3.1 | 2.7 ± 1.3 | < 0.01 |
Albumin (3.3–5.5 g/dL) | 3.9 ± 0.4 | 3.9 ± 0.4 | 0.30 |
Cholesterol (110–200 mg/dL) | 165.0 ± 43.7 | 159.0 ± 61.0 | 0.59 |
Values are presented as mean ± standard deviation or number (%).
AST, aspartate transaminase; ALT, alanine transaminase; ALP, alkaline phosphatase; GGT, gamma-glutamyl transferase.